X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Sun Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs SUN PHARMA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER SUN PHARMA PFIZER/
SUN PHARMA
 
P/E (TTM) x 28.4 26.2 108.1% View Chart
P/BV x 4.5 3.8 117.6% View Chart
Dividend Yield % 0.7 0.6 119.8%  

Financials

 PFIZER   SUN PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-16
SUN PHARMA
Mar-17
PFIZER/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,724842 323.5%   
Low Rs1,611572 281.4%   
Sales per share (Unadj.) Rs440.9131.6 335.0%  
Earnings per share (Unadj.) Rs48.732.7 148.9%  
Cash flow per share (Unadj.) Rs75.838.0 199.5%  
Dividends per share (Unadj.) Rs15.003.50 428.6%  
Dividend yield (eoy) %0.70.5 139.8%  
Book value per share (Unadj.) Rs462.9152.7 303.2%  
Shares outstanding (eoy) m45.752,399.26 1.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.95.4 91.5%   
Avg P/E ratio x44.521.6 205.8%  
P/CF ratio (eoy) x28.618.6 153.6%  
Price / Book Value ratio x4.74.6 101.1%  
Dividend payout %30.810.7 287.8%   
Avg Mkt Cap Rs m99,1631,696,877 5.8%   
No. of employees `0002.917.5 16.5%   
Total wages/salary Rs m2,75849,023 5.6%   
Avg. sales/employee Rs Th6,981.718,028.3 38.7%   
Avg. wages/employee Rs Th954.52,798.8 34.1%   
Avg. net profit/employee Rs Th771.14,479.5 17.2%   
INCOME DATA
Net Sales Rs m20,170315,784 6.4%  
Other income Rs m8576,232 13.8%   
Total revenues Rs m21,028322,016 6.5%   
Gross profit Rs m4,310100,893 4.3%  
Depreciation Rs m1,23912,648 9.8%   
Interest Rs m53,998 0.1%   
Profit before tax Rs m3,92390,479 4.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m099 0.0%   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,79412,116 14.8%   
Profit after tax Rs m2,22878,462 2.8%  
Gross profit margin %21.431.9 66.9%  
Effective tax rate %45.713.4 341.6%   
Net profit margin %11.024.8 44.5%  
BALANCE SHEET DATA
Current assets Rs m16,299329,537 4.9%   
Current liabilities Rs m7,594178,870 4.2%   
Net working cap to sales %43.247.7 90.5%  
Current ratio x2.11.8 116.5%  
Inventory Days Days6579 82.6%  
Debtors Days Days2683 30.9%  
Net fixed assets Rs m8,622204,766 4.2%   
Share capital Rs m4582,399 19.1%   
"Free" reserves Rs m20,722363,997 5.7%   
Net worth Rs m21,180366,397 5.8%   
Long term debt Rs m2514,361 0.2%   
Total assets Rs m29,137614,102 4.7%  
Interest coverage x755.523.6 3,197.0%   
Debt to equity ratio x00 3.0%  
Sales to assets ratio x0.70.5 134.6%   
Return on assets %7.713.4 57.1%  
Return on equity %10.521.4 49.1%  
Return on capital %19.024.8 76.5%  
Exports to sales %0.10-   
Imports to sales %17.50-   
Exports (fob) Rs m12NA-   
Imports (cif) Rs m3,526NA-   
Fx inflow Rs m5244,118 0.1%   
Fx outflow Rs m14024,484 0.6%   
Net fx Rs m-8819,634 -0.4%   
CASH FLOW
From Operations Rs m3,43670,822 4.9%  
From Investments Rs m-6,991-42,216 16.6%  
From Financial Activity Rs m-619-22,854 2.7%  
Net Cashflow Rs m-4,1746,107 -68.3%  

Share Holding

Indian Promoters % 0.0 63.7 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 5.1 146.2%  
FIIs % 4.9 23.0 21.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 8.3 285.5%  
Shareholders   85,207 133,026 64.1%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   STRIDES SHASUN LTD  AJANTA PHARMA  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Rising Stock Markets, Reduction in Government's Additional Borrowing, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed on a strong note yesterday. At the closing bell yesterday, the BSE Sensex crossed its 35,000 mark for the first time and stood higher by 311 points (up 0.9%).

Related Views on News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jan 17, 2018 (Close)

TRACK PFIZER

PFIZER - WOCKHARDT LTD. COMPARISON

COMPARE PFIZER WITH

MARKET STATS